Cosmetic Compliance
Intelligence & Solutions
Guidelines for the Advance Notice of Importation Process for Cosmetics and Drugs
Local Title:
Guidelines for the Advance Notice of Importation Process for Cosmetics and Drugs
Country/Region:
Canada
Competent Authority:
Health Canada
Type:
Guideline
Status:
In force
Release Date:
2022-02-22
Implementation Date:
2022-02-22
Document
Language Source Title Access
EN
Official Guidelines for the Advance Notice of Importation Process for Cosmetics and Drugs
Summary

Importing non-compliant cosmetics and drugs (including health products) for the purpose of sale is prohibited under the Cosmetic Regulations (CR) and Food and Drug Regulations (FDR). However, both of these regulations allow for non-compliant cosmetics and drugs to be imported under 2 conditions:

  • the importer provides advance notice to a Health Canada inspector of the proposed importation

  • the product is relabelled or modified as required for its lawful sale in Canada

The advance notice of importation process must be followed as per s. 9 of the Cosmetic Regulations and A.01.044 of the Food and Drug Regulations. It applies to:

  • cosmetics requiring modification or relabelling prior to being sold as cosmetics in Canada

  • drugs requiring modification or relabelling prior to being sold as cosmetics in Canada

  • drugs requiring modification or relabelling prior to being sold as foods in Canada

  • drugs that hold a valid Canadian market authorization (Drug Identification Number (DIN)/Homeopathic Medicine Number (DIN-HM)/Natural Product Number (NPN)) and require modification or relabelling prior to being sold as drugs in Canada

Content

1. Background

2. Scope

3. Advance notice of importation

4. At the border

5. Compliance and enforcement

User Guide